Case Report
Published on 17 Nov 2025
Response to dabrafenib and trametinib combined with pembrolizumab in an elderly patient with lung adenocarcinoma of unknown primary harboring BRAF V600E mutation and high PD-L1 expression: a case report
in Cancer Immunity and Immunotherapy
- 446 views